Skip to Content

Hayat Pharmaceutical Industries Co HPIC

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

HPIC is trading at a 746% premium.
Price
JOD 2.49
Fair Value
JOD 6.76
Uncertainty
Extreme
1-Star Price
JOD 1.88
5-Star Price
JOD 8.30
Economic Moat
Bjgtytv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HPIC is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
10.16
Price/Sales
1.53
Dividend Yield (Trailing)
6.63%
Dividend Yield (Forward)
6.63%
Total Yield
6.63%

Company Profile

Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. Its principal activity is producing human and veterinary in all its forms and medical stickers and stockings. The company is also involved in the production of medical supplies, body care lotions, cosmetics and initiating marketing campaigns as well as import and export operations. It has developed and registered hundred sixteen different dosage forms/pack sizes in the Jordan market representing fifty six different brands (molecules) in various therapeutic areas. Its products include Cardiovascular system, Infectious disease Dermatology, Gastrointestinal system, and Respiratory system.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
196

Valuation

Metric
HPIC
Price/Earnings (Normalized)
10.16
Price/Book Value
0.80
Price/Sales
1.53
Price/Cash Flow
Price/Earnings
HPIC

Financial Strength

Metric
HPIC
Quick Ratio
3.75
Current Ratio
4.79
Interest Coverage
Quick Ratio
HPIC

Profitability

Metric
HPIC
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
HPIC
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
YnkjgqzstwVbpjjw$80.3 Bil
Zoetis Inc Class A
ZTS
WglkwmlyhCdd$77.8 Bil
Haleon PLC ADR
HLN
ZwhffbdfQkcc$37.8 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
RbkmnbbWfvx$12.1 Bil
Viatris Inc
VTRS
CzldcqhpHvph$12.1 Bil
Catalent Inc
CTLT
LzthfcnqYzrbmz$10.0 Bil
Perrigo Co PLC
PRGO
LhgxwdgKzsm$3.7 Bil
Prestige Consumer Healthcare Inc
PBH
LqhtrgkdmCfgzvg$3.2 Bil
Curaleaf Holdings Inc
CURLF
DryzsqhcSkxq$3.0 Bil
Green Thumb Industries Inc
GTBIF
SvjrbybcqMclc$2.7 Bil

Sponsor Center